Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStorr, Julie-
dc.contributor.authorTwyman, Anthony-
dc.contributor.authorZingg, Walter-
dc.contributor.authorDamani, Nizam-
dc.contributor.authorKilpatrick, Claire-
dc.contributor.authorReilly, Jacqui-
dc.contributor.authorPrice, Lesley-
dc.contributor.authorEgger, Matthias-
dc.contributor.authorGrayson, M Lindsay-
dc.contributor.authorKelley, Edward-
dc.contributor.authorAllegranzi, Benedetta-
dc.identifier.citationAntimicrobial Resistance & Infection Control 2017; 6: 6en_US
dc.description.abstractHealth care-associated infections (HAI) are a major public health problem with a significant impact on morbidity, mortality and quality of life. They represent also an important economic burden to health systems worldwide. However, a large proportion of HAI are preventable through effective infection prevention and control (IPC) measures. Improvements in IPC at the national and facility level are critical for the successful containment of antimicrobial resistance and the prevention of HAI, including outbreaks of highly transmissible diseases through high quality care within the context of universal health coverage. Given the limited availability of IPC evidence-based guidance and standards, the World Health Organization (WHO) decided to prioritize the development of global recommendations on the core components of effective IPC programmes both at the national and acute health care facility level, based on systematic literature reviews and expert consensus. The aim of the guideline development process was to identify the evidence and evaluate its quality, consider patient values and preferences, resource implications, and the feasibility and acceptability of the recommendations. As a result, 11 recommendations and three good practice statements are presented here, including a summary of the supporting evidence, and form the substance of a new WHO IPC guideline.en_US
dc.subjectInfection prevention and controlen_US
dc.subjectIPC programmesen_US
dc.subjectHand hygieneen_US
dc.subjectAntimicrobial resistanceen_US
dc.subjectIPC guidelineen_US
dc.subjectMultimodal strategyen_US
dc.subjectIPC educationen_US
dc.subjectBed occupancyen_US
dc.subjectIPC practicesen_US
dc.subjectUniversal health coverageen_US
dc.titleCore components for effective infection prevention and control programmes: new WHO evidence-based recommendationsen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleAntimicrobial Resistance & Infection Controlen_US
dc.identifier.affiliationInfection Prevention and Control Global Unit, Service Delivery and Safety, HIS, World Health Organization, Geneva, Switzerlanden_US
dc.identifier.affiliationInfection Control Programme, and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerlanden_US
dc.identifier.affiliationGlasgow Caledonian University, Cowcaddens Road, Glasgow, UKen_US
dc.identifier.affiliationInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerlanden_US
dc.identifier.affiliationAustin Healthen_US
dc.contributor.corpauthorWHO Guidelines Development Group-
dc.type.austinJournal Articleen_US, M Lindsay
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.grantfulltextnone- Diseases-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Jul 24, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.